Key Corporate Management

César M. García, Chief Executive Officer and President, joined the company in January 2002 as Executive Vice President, was elevated to President in June 2003, and appointed Chief Executive Officer in November 2003. Mr. García has over 30 years of experience in medical device manufacturing. Prior to joining the Company, Mr. García was Sr. Vice President, Operations and Program Management for Cytometrics Inc., of Philadelphia, PA., an early stage manufacturer of non-invasive, photonics-based medical devices. From 1994 to 1998, he was Vice President of Operations and Engineering at Datascope Corp. of Mahwah, NJ, which manufactures medical devices for interventional cardiology, anesthesiology and critical care monitoring. From 1974 through 1994, Mr. García worked with Bayer assuming positions of increased responsibility including General Manager of Technicon Electronics Corp., a subsidiary of Bayer USA and Director Worldwide Hematology Manufacturing and Cellular Diagnostics Research and Development. Mr. García earned his B.S. in Industrial Engineering (Cum Laude) at the University of Puerto Rico and received an Advanced Management Certificate from Pace University, Pleasantville, NY.

Peter Donato joined the company in August 2007 as Corporate Vice President and Chief Financial Officer. Peter has over 15 years of progressive experience managing financial organizations including enterprises in medical device manufacturing. Prior to joining IRIS, Mr. Donato served as Vice President and CFO, for Gamma Medica-Ideas Inc., an early stage manufacturer of medical imaging equipment. From 2003 to 2006, he was Vice President of Finance for the Cardiology Division of Accellent, Inc., which manufactures medical devices for interventional cardiology applications. From 2001 to 2003, Mr. Donato worked for the Scotts-Miracle Gro Company in various Divisional Controllership roles. From 1994-2000, Mr. Donato worked in the automotive industry with both General Motors and Honda after beginning his career in public accounting with Ernst and Young. Mr. Donato earned his B.S.B.A. in Accounting (Magna Cum Laude) at The Ohio State University and received an M.B.A. from the College of Business Administration at the University of Akron (Ohio). Mr. Donato is also a licensed Certified Public Accountant.

Robert A. Mello joined the Company in April 2000 as Corporate Vice President and General Manager of the Iris Sample Processing Subsidiary and was promoted to President of Iris Sample Processing in April 2002. Mr. Mello has 29 years of experience in medical device manufacturing, service, marketing and engineering. Prior to joining Iris Sample Processing, Mr. Mello was Vice President of Operations with bioMerieux, for their Boston Immunoassay and Molecular Diagnostics facility. Before that, he was Vice President of Disposables Manufacturing at bioMerieux's clinical microbiology facility in St. Louis. Prior to joining bioMerieux, he held senior management positions with Medical & Scientific Designs and Ortho Diagnostics Inc., a division of Johnson & Johnson. Mr. Mello holds a degree in Electrical Engineering from Bristol College in Fall River, MA and a B.S. in Management from Leslie University, Boston, MA.

John Yi, Vice President of Operations, joined Iris Diagnostics in September, 2003. John is responsible for Manufacturing, Material Control, Purchasing, Parts Repair and Operations Engineering. John holds a Bachelor's degree in Business Administration/Accounting from California State University in Hayward, California. He brings to Iris an excellent track record in operations management, program management, engineering technical services and significant experience in high-growth, high revenue manufacturing companies. Most recently, John was Vice President of Operations with Alcatel Corporation (formerly Xylan) and prior to that he held positions of similar responsibility at Micropolis and Seagate Technology.